Morgan Stanley Raises Philip Morris (PM) Target on Confidence in Zyn and IQOS Growth
Key takeaways
- Morgan Stanley Raises Philip Morris (PM) Target on Confidence in Zyn and IQOS Growth Vardah Gill Thu, June 4, 2026 at 10:12 PM GMT+7 2 min read PM Philip Morris International Inc.
- On June 2, Reuters reported that Philip Morris lowered its annual profit forecast because of currency fluctuations.
- Speaking at the Deutsche Bank Global Consumer Conference, Olczak said recent U.S.
Morgan Stanley Raises Philip Morris (PM) Target on Confidence in Zyn and IQOS Growth Vardah Gill Thu, June 4, 2026 at 10:12 PM GMT+7 2 min read PM Philip Morris International Inc. (NYSE:PM) is included among the 10 No-Brainer Dividend Stocks to Buy.
On June 3, Morgan Stanley raised its price recommendation on Philip Morris International Inc. (NYSE:PM) to $200 from $190. It reiterated an Overweight rating on the shares. The firm said its confidence improved following updates shared by Philip Morris at a recent investor conference. The company announced that Zyn Ultra will launch in the U.S. this month and also provided an update on IQOS in Japan. At the same time, Morgan Stanley lowered its Q2 and full-year 2026 estimates by $0.05 per share to reflect foreign exchange impacts, in line with the company’s updated outlook.
On June 2, Reuters reported that Philip Morris lowered its annual profit forecast because of currency fluctuations. Even so, CEO Jacek Olczak said other risks to achieving the company’s outlook, including rising energy prices, were manageable.